Navigation Links
Neurologix to Present at the Third Annual C.E. Unterberg Towbin,Emerging Growth Conference

FORT LEE, N.J.--(BUSINESS WIRE)--Jul 6, 2007 - Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference on Tuesday July 10, 2007 at 4:30 pm ET at The Mandarin Oriental Hotel in New York.

President and Chief Executive Officer John Mordock will discuss Neurologix's business and product development. The audio portion of the presentation will be webcast live, and a replay will be available shortly after the actual presentation time for 90 days on the Investor Relations page of the company's website at www.neurologix.net.

About Neurologix

Neurologix, Inc. is a development-stage company engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system utilizing gene therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease, epilepsy and other neurodegenerative and metabolic disorders. Neurologix's core technology, "NLX," is currently in clinical stages of development, having recently completed a Phase I human clinical trial to treat Parkinson's disease and with additional trials in that indication and in epilepsy planned.

Contact

Neurologix, Inc.
Marc Panoff, 201-592-6451
Chief Financial Officer
marcpanoff@neurologix.net


'"/>




Page: 1

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 TFS is pleased ... Mr. Ed Tumaian , two global executive positions in Medical ... joining the Operational Leadership Team and will report to Dr. ... ... to TFS with 10 years of medical and scientific expertise gained ...
(Date:3/22/2017)... N.Y. , March 22, 2017  As the ... Leukemia & Lymphoma Society (LLS) has played a role ... patients, some of which are even helping patients with ... due to LLS,s significant investment in cutting-edge research – ... milestone continues to grow with the record-breaking sum of ...
(Date:3/22/2017)... NetworkNewsWire Editorial Coverage  ... Deciphering marijuana policy under the Trump ... officials. Federal laws are at odds with a number of ... and businesses like SinglePoint, Inc. (OTC: SING) ( SING Profile ... (OTC: MJNA), Cannabis Science, Inc. (OTC: CBIS) and ChineseInvestors.com, Inc. ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the India ... need of skilled pediatric dentistry in Rock Hill, SC, without a referral. ... treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, LLC, ... experience and operational excellence in oncology clinical trials, proudly announces today that it ... of non-small cell lung cancer and small cell lung cancer. , Throughout this ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... financial planning, and related services to communities across eastern Texas, is announcing a ... of providing meals to hungry children and adults. , Consistently a top-rated ...
(Date:3/22/2017)... NC (PRWEB) , ... March 22, 2017 , ... Chris ... assistance to families and business professionals throughout the coastal plains region, is initiating a ... to overcome cancer. , Dillyn was first diagnosed with leukemia on a Friday evening ...
(Date:3/22/2017)... CANADA (PRWEB) , ... March 22, 2017 , ... HumanHaus ... today, the Sweep&Stand. The conventional broom was great when it was invented, but ... They are the working parents, the social young couple, the empty nesters and retired ...
Breaking Medicine News(10 mins):